Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice

Plasmodium falciparum has exerted tremendous selective pressure on genes that improve survival in severe malarial infections. Systemic lupus erythematosus (SLE) is an autoimmune disease that is six to eight times more prevalent in women of African descent than in women of European descent. Here we p...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 108; no. 3; pp. 1122 - 1127
Main Authors: Waisberg, Michael, Tarasenko, Tatyana, Vickers, Brandi K., Scott, Bethany L., Willcocks, Lisa C., Molina-Cruz, Alvaro, Pierce, Matthew A., Huang, Chiung-yu, Torres-Velez, Fernando J., Smith, Kenneth G. C., Barillas-Mury, Carolina, Miller, Louis H., Pierce, Susan K., Bolland, Silvia
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 18-01-2011
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Plasmodium falciparum has exerted tremendous selective pressure on genes that improve survival in severe malarial infections. Systemic lupus erythematosus (SLE) is an autoimmune disease that is six to eight times more prevalent in women of African descent than in women of European descent. Here we provide evidence that a genetic susceptibility to SLE protects against cerebral malaria. Mice that are prone to SLE because of a deficiency in FcγRIIB or overexpression of Toll-like receptor 7 are protected from death caused by cerebral malaria. Protection appears to be by immune mechanisms that allow SLE-prone mice better to control their overall inflammatory responses to parasite infections. These findings suggest that the high prevalence of SLE in women of African descent living outside of Africa may result from the inheritance of genes that are beneficial in the immune control of cerebral malaria but that, in the absence of malaria, contribute to autoimmune disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: M.W., T.T., K.G.C.S., C.B.-M., L.H.M., S.K.P., and S.B. designed research; M.W., T.T., B.K.V., B.L.S., L.C.W., A.M.-C., M.A.P., and F.J.T.-V. performed research; M.W., T.T., C.-y.H., F.J.T.-V., K.G.C.S., C.B.-M., L.H.M., S.K.P., and S.B. analyzed data; and M.W., K.G.C.S., C.B.-M., L.H.M., S.K.P., and S.B. wrote the paper.
Contributed by Louis H. Miller, December 9, 2010 (sent for review October 14, 2010)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1017996108